Exploring the gut microbiota and its potential as a biomarker in gliomas
| العنوان: | Exploring the gut microbiota and its potential as a biomarker in gliomas |
|---|---|
| المؤلفون: | Aljarrah, Dana, Chalour, Naima, Zorgani, Amine, Nissan, Tracy, 1971, Pranjol, Md Zahidul I. |
| المصدر: | Biomedicine and Pharmacotherapy. 173 |
| مصطلحات موضوعية: | Glioma, Glioblastoma multiforme, Biomarker, Gut microbiome, Gut-brain axis, Intratumoural microbiome, Tumour microenvironment, Metabolites |
| الوصف: | Gut microbiome alterations are associated with various cancers including brain tumours such as glioma and glioblastoma. The gut communicates with the brain via a bidirectional pathway known as the gut-brain axis (GBA) which is essential for maintaining homeostasis. The gut microbiota produces many metabolites including short chain fatty acids (SCFAs) and essential amino acids such as glutamate, glutamine, arginine and tryptophan. Through the modulation of these metabolites the gut microbiome is able to regulate several functions of brain cells, immune cells and tumour cells including DNA methylation, mitochondrial function, the aryl hydrocarbon receptor (AhR), T-cell proliferation, autophagy and even apoptosis. Here, we summarise current findings on gut microbiome with respect to brain cancers, an area of research that is widely overlooked. Several studies investigated the relationship between gut microbiota and brain tumours. However, it remains unclear whether the gut microbiome variation is a cause or product of cancer. Subsequently, a biomarker panel was constructed for use as a predictive, prognostic and diagnostic tool with respect to multiple cancers including glioma and glioblastoma multiforme (GBM). This review further presents the intratumoural microbiome, a fascinating microenvironment within the tumour as a possible treatment target that can be manipulated to maximise effectiveness of treatment via personalised therapy. Studies utilising the microbiome as a biomarker and therapeutic strategy are necessary to accurately assess the effectiveness of the gut microbiome as a clinical tool with respect to brain cancers. |
| وصف الملف: | |
| URL الوصول: | https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-232239 https://doi.org/10.1016/j.biopha.2024.116420 |
| قاعدة البيانات: | SwePub |
Full Text via ClinicalKey | تدمد: | 07533322 19506007 |
|---|---|
| DOI: | 10.1016/j.biopha.2024.116420 |